Chromatographic purity · O-018
HPLC and UPLC peptide purity results
A purity percentage is method-bound. It commonly reports relative chromatographic peak area under stated conditions. It does not automatically equal peptide mass fraction or prove identity.
An HPLC or UPLC peptide purity result shows how the sample separated under the reported chromatographic conditions and how the laboratory calculated the main peak relative to detected peaks. The percentage does not, on its own, establish molecular identity, absolute quantity, sterility, endotoxin status or the contents of another vial.
UPLC is a high-pressure form of liquid chromatography. Column chemistry, mobile phase, detector, wavelength, elution programme, sample preparation and integration rules can change which components appear and how the area percentage is calculated.
What does a chromatographic purity percentage measure?
Many peptide certificates report an area percentage: the integrated area of the selected main peak divided by the total area of peaks included in the calculation. The figure describes detector response within that run. It is not automatically a gravimetric percentage of peptide in the vial. Read where this figure appears on the certificate before treating it as a batch-level conclusion.
A peak can represent more than one unresolved component. A component may also respond weakly, fall outside the detector settings or be excluded by the integration method. The report needs the procedure and chromatogram for interpretation.
“99% by HPLC” means a chromatographic result under stated conditions. It does not mean 99% of the vial is the intended peptide.
Why can two reported percentages differ?
| Field | Why it changes the result | What to look for |
|---|---|---|
| Separation | A different column or elution programme can resolve or merge peaks. | Column, mobile phases, elution programme and run time |
| Detection | A detector records only what it can see under its settings. | Detector type and wavelength |
| Integration | Peak boundaries and exclusions alter area calculations. | Integration rules and the full trace |
| Reference | Retention time has value only within a controlled method. | Reference standard and system-suitability record |
What can HPLC support, and what remains unknown?
| Question | HPLC or UPLC can support | Still needs separate evidence |
|---|---|---|
| Chromatographic purity | Relative profile and related peaks under the method conditions. | Identity confirmation and absolute assay |
| Identity | Retention can support identity when a validated method and reference standard provide adequate discrimination. | Orthogonal confirmation where closely related structures or substitutions matter |
| Safety | The trace may reveal detected related components. | Sterility, endotoxin, microbial quality, particulate and unmeasured contaminants |
| Your vial | A result describes the submitted sample. | Document-to-vial match and sample provenance |
Checks before accepting a purity claim
- Name the calculationLook for area percentage, assay, corrected content or another defined result. Do not treat them as synonyms.
- Read the method detailsRecord the column, detector, wavelength, elution programme, run time and reference material where reported.
- Inspect the traceCheck peak count, integration boundaries, baseline and any unresolved shoulders.
- Ask what was excludedSolvent fronts, system peaks and thresholds can affect the denominator.
- Pair the result with identityA clean chromatogram can still belong to the wrong molecule if identity was not established.
Continue the evidence check
Questions readers ask
Does a 99% HPLC result prove the peptide is correct?
No. A high chromatographic area percentage can support a purity statement under the stated method, but it does not establish molecular identity unless the method was validated for identification. Identity needs its own evidence, often including mass spectrometry or another orthogonal technique.
Is UPLC more trustworthy than HPLC?
The label alone does not decide trustworthiness. UPLC can provide efficient high-resolution separations, but confidence depends on the method's fitness for purpose, validation, system suitability, sample provenance and full reporting. A poorly specified UPLC result can be less useful than a well-documented HPLC result.
Does HPLC show how much peptide is in a vial?
A chromatographic purity percentage does not usually establish the absolute mass of peptide in the vial. Quantity requires an assay or another calibrated quantitative procedure, with sample preparation, reference material, calculation and uncertainty suitable for that purpose.
Can HPLC prove a vial is sterile?
No. Chromatography does not replace sterility, bacterial endotoxin, microbial or particulate testing. If those tests are absent, those safety attributes remain unmeasured rather than passed.
Primary sources and update triggers
- EMA: ICH Q2(R2) Validation of Analytical Procedures: validation for identity, assay, purity, impurities and other intended analytical purposes
- Eurachem: The Fitness for Purpose of Analytical Methods: method validation, detection capability, precision and fitness for purpose
- EDQM: Technical guide for synthetic peptide monographs: orthogonal identity, chromatographic and peptide-mapping approaches
Editorial experience
From our work: how we checked this page
For topical-map item O-018, HPLC and UPLC peptide purity results was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 3 unique external sources and 7 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.